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The PINK1/BRPK gene encodes a serine/threonine
kinase with a mitochondrial localization signal. Muta-
tions in the gene is causatively linked to an autosomal
recessive form of Parkinson’sd i s e a s e( P D ) .W es h o w e d
that PINK1/BRPK was expressed at a higher level in
cancer cell lines with higher metastatic potential. When
overexpressed, PINK1/BRPK blocked apoptotic cell
death of cancer cells induced by various agents, includ-
ing oxidative stress. Overexpression of wild-type PINK1/
BRPK induced phosphorylation of Akt, an important
anti-apoptotic protein. PINK1/BRPK protein is mostly
localized in the mitochondria, but the protein is also
detected in the cytoplasm and co-precipitated with Akt.
Application of an Akt inhibitor abrogated the anti-
apoptotic effect of PINK1/BRPK. Blocking the EGF
receptor-PI3 kinase pathway, an authentic upstream
pathway for Akt activation, did not affect phosphoryla-
tion of Akt by PINK1/BRPK, indicating that PINK1/
BRPK activates Akt through a mechanism independent
from the receptor-PI3 kinase pathway.
Another known upstream effector for Akt is
mTORC2. We therefore examined mTORC2 in SH-
SY5Y cells with overexpression of PINK1. PINK1/BRPK
was co-precipitated with components of mTORC2 but
not with a component of mTORC1. Prolonged treat-
ment with rapamycin that is known to inhibit mTORC2
cancelled the effect of PINK1/BRPK, while brief treat-
ment with rapamycin that is specific to mTORC1
showed no effect. Furthermore, overexpression of
PINK1/BRPK enhanced cellular invasiveness in vitro.
These results indicate that mTORC2 is a critical
molecule to mediate the anti-apoptotic and pro-
metastatic activity of PINK1/BRPK.
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